{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:54:32Z","timestamp":1759056872109},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s00415-005-1102-7","type":"journal-article","created":{"date-parts":[[2005,6,15]],"date-time":"2005-06-15T20:55:54Z","timestamp":1118868954000},"page":"i1-i6","source":"Crossref","is-referenced-by-count":23,"title":["Intravenous immunoglobulin in neurological disorders: a mechanistic perspective"],"prefix":"10.1007","volume":"252","author":[{"given":"Namita","family":"Misra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagadeesh","family":"Bayry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Ephrem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suryasarathi","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Delignat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul Duong","family":"Huyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Prost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastien","family":"Lacroix-Desmazes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel D.","family":"Kazatchkine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srini V.","family":"Kaveri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1102_CR1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1212\/WNL.50.2.398","volume":"50","author":"Achiron","year":"1998","unstructured":"Achiron A, Gabbay U, Hassin-Baer S, Barrk Y, Gornish M, Elizur A, Goldhammer Y, Sarova-Pinhas I (1998) Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses. Neurology 50:398\u2013402","journal-title":"Neurology"},{"key":"1102_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cei.1996.104.s1.10","volume":"104","author":"Andersson","year":"1996","unstructured":"Andersson J, Skansen-Saphir U, Sparrelid E, Andersson U (1996) Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes\/macrophages. Clin Exp Immunol 104:10\u201320","journal-title":"Clin Exp Immunol"},{"key":"1102_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-065X.1994.tb00855.x","volume":"139","author":"Andersson","year":"1994","unstructured":"Andersson U, Bjork L, Skansen SU, Andersson J (1994) Pooled human IgG modulates cytokine production in lymphocytes and monocytes. Immunol Rev 139:21\u201342","journal-title":"Immunol Rev"},{"key":"1102_CR4","first-page":"211","volume":"79","author":"Andersson","year":"1993","unstructured":"Andersson UG, Bjork L, Skans\u00e9n-Saphir U, Andersson JP (1993) Downregulation of cytokine production and IL-2 receptor expression by pooled human IgG. Immunology 79:211\u2013216","journal-title":"Immunology"},{"key":"1102_CR5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0091-6749(97)70217-3","volume":"100","author":"Ballow","year":"1997","unstructured":"Ballow M (1997) Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases. J Allergy Clin Immunol 100:151\u2013157","journal-title":"J Allergy Clin Immunol"},{"key":"1102_CR6","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1172\/JCI117520","volume":"94","author":"Basta","year":"1994","unstructured":"Basta M, Dalakas MC (1994) High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complements fragments. J Clin Invest 94:1729\u20131735","journal-title":"J Clin Invest"},{"key":"1102_CR7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood.V77.2.376.376","volume":"77","author":"Basta","year":"1991","unstructured":"Basta M, Fries LF, Frank MM (1991) High-dose intravenous immunoglobulin inhibits in vitro uptake of C4 fragments on to sensitized erythrocytes. Blood 77:376\u2013380","journal-title":"Blood"},{"key":"1102_CR8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nm836","volume":"9","author":"Basta","year":"2003","unstructured":"Basta M, Van Goor F, Luccioli S, Billings EM, Vortmeyer AO, Baranyi L, Szebeni J, Alving CR, Carroll MC, Berkower I, Stojilkovic SS, Metcalfe DD (2003) F(ab)\u20192-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. Nat Med 9:431\u2013438","journal-title":"Nat Med"},{"key":"1102_CR9","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood-2002-05-1447","volume":"101","author":"Bayry","year":"2003","unstructured":"Bayry J, Lacroix-Desmazes S, Carbonneil C, Misra N, Donkova V, Pashov A, Chevalliar A, Mouthon L, Weill B, Bruneval P, Kazatchkine MD, Kaveri SV (2003) Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood 101:758\u2013765","journal-title":"Blood"},{"key":"1102_CR10","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1002\/art.11346","volume":"48","author":"Bayry","year":"2003","unstructured":"Bayry J, Lacroix-Desmazes S, Delignat S, Mouthon L, Weill B, Kazatchkine MD, Kaveri SV (2003) Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-alpha present in serum from patients with systemic lupus erythematosus. Arthritis Rheum 48:3497\u20133502","journal-title":"Arthritis Rheum"},{"key":"1102_CR11","doi-asserted-by":"crossref","first-page":"14210","DOI":"10.1073\/pnas.0402183101","volume":"101","author":"Bayry","year":"2004","unstructured":"Bayry J, Lacroix-Desmazes S, Donkova-Petrini V, Carbonneil C, Misra N, Lepelletier Y, Delignat S, Varambally S, Oksenhendler E, L\u00e9vy Y, Debr\u00e9 M, Kazatchkine MD, Hermine O, Kaveri SV (2004) Natural antibodies sustain differentiation and maturation of human dendritic cells. Proc Natl Acad Sci USA 101:14210\u201314215","journal-title":"Proc Natl Acad Sci USA"},{"key":"1102_CR12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.tips.2004.04.002","volume":"25","author":"Bayry","year":"2004","unstructured":"Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV (2004) Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era? Trends Pharmacol Sci 25:306\u2013310","journal-title":"Trends Pharmacol Sci"},{"key":"1102_CR13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0167-5699(98)01252-3","volume":"19","author":"Bendtzen","year":"1998","unstructured":"Bendtzen K, Hansen MB, Ross C, Svenson M (1998) High-avidity autoantibodies to cytokines. Immunol Today 19:209\u2013211","journal-title":"Immunol Today"},{"key":"1102_CR14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0140-6736(93)90563-V","volume":"341","author":"Blasczyk","year":"1993","unstructured":"Blasczyk R, Westhoff U, Grossewilde H (1993) Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations. Lancet 341:789\u2013790","journal-title":"Lancet"},{"key":"1102_CR15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(03)00080-3","volume":"18","author":"Bruhns","year":"2003","unstructured":"Bruhns P, Samuelsson A, Pollard JW, Ravetch JV (2003) Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity 18:573\u2013581","journal-title":"Immunity"},{"key":"1102_CR16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2003-01-0023","volume":"102","author":"Crow","year":"2003","unstructured":"Crow AR, Song S, Freedman J, Helgason CD, Humphries RK, Siminovitch KA, Lazarus AH (2003) IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity. Blood 102:558\u2013560","journal-title":"Blood"},{"key":"1102_CR17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7326\/0003-4819-126-9-199705010-00008","volume":"126","author":"Dalakas","year":"1997","unstructured":"Dalakas MC (1997) Intravenous immune globulin therapy for neurologic diseases. Ann Intern Med 126:721\u2013730","journal-title":"Ann Intern Med"},{"key":"1102_CR18","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1001\/jama.291.19.2367","volume":"291","author":"Dalakas","year":"2004","unstructured":"Dalakas MC (2004) Intravenous immunoglobulin in autoimmune neuromuscular diseases. Jama 291:2367\u20132375","journal-title":"Jama"},{"key":"1102_CR19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1212\/WNL.51.6_Suppl_5.S2","volume":"51","author":"Dalakas","year":"1998","unstructured":"Dalakas MC (1998) Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases. Neurology 51:2\u20138","journal-title":"Neurology"},{"key":"1102_CR20","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa01167","volume":"345","author":"Dalakas","year":"2001","unstructured":"Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B (2001) High-dose intravenous immune globulin for stiffperson syndrome. N Engl J Med 345:1870\u20131876","journal-title":"N Engl J Med"},{"key":"1102_CR21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJM199201093260206","volume":"326","author":"Dwyer","year":"1992","unstructured":"Dwyer JM (1992) Manipulating the immune system with immune globulin. N Engl J Med 326:107\u2013116","journal-title":"N Engl J Med"},{"key":"1102_CR22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0140-6736(96)09377-4","volume":"349","author":"Fazekas","year":"1997","unstructured":"Fazekas F, Deisenhammer F, Strasser-Fuchs S, Nahler G, Mamoll B, FTAI-IMSS group (1997) Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting sclerosis. Lancet 349:589\u2013593","journal-title":"Lancet"},{"key":"1102_CR23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/cei.1996.104.s1.61","volume":"104","author":"Gelfand","year":"1996","unstructured":"Gelfand E, Landwehr L, Esterl B, Mazer B (1996) Intravenous immune globulin: an alternative therapy in steroiddependent allergic diseases. Clin Exp Immunol 104:61\u201366","journal-title":"Clin Exp Immunol"},{"key":"1102_CR24","first-page":"269","volume":"1","author":"Hurez","year":"1994","unstructured":"Hurez V, Kaveri SV, Mouhoub A, Dietrich G, Mani JC, Klatzmann D, Kazatchkine MD (1994) Anti-CD4 activity of normal human immunoglobulins G for therapeutic use (Intravenous immunoglobulin, IVIg). Therap Immunol 1:269\u2013278","journal-title":"Therap Immunol"},{"key":"1102_CR25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1172\/JCI118488","volume":"97","author":"Kaveri","year":"1996","unstructured":"Kaveri S, Vassilev T, Hurez V, Lengagne R, Cot S, Pouletty P, Glotz D, Kazatchkine M (1996) Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use (IVIg). J Clin Invest 97:865\u2013869","journal-title":"J Clin Invest"},{"key":"1102_CR26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-065X.1994.tb00858.x","volume":"139","author":"Kazatchkine","year":"1994","unstructured":"Kazatchkine MD, Dietrich G, Hurez V, Ronda N, Bellon B, Rossi F, Kaveri SV (1994) V Region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (IVIg). Immunol Rev 139:79\u2013107","journal-title":"Immunol Rev"},{"key":"1102_CR27","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","volume":"345","author":"Kazatchkine","year":"2001","unstructured":"Kazatchkine MD, Kaveri SV (2001) Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345:747\u2013755","journal-title":"N Engl J Med"},{"key":"1102_CR28","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/0140-6736(93)91784-J","volume":"342","author":"Lam","year":"1993","unstructured":"Lam L, Whitsett CF, McNicholl JM, Hodge TW, Hooper J (1993) Immunologically active proteins in intravenous immunoglobulin. Lancet 342:678","journal-title":"Lancet"},{"key":"1102_CR29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1182\/blood-2003-05-1530","volume":"103","author":"Lutz","year":"2004","unstructured":"Lutz HU, Stammler P, Bianchi V, Trueb RM, Hunziker T, Burger R, Jelezarova E, Spath PJ (2004) Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level. Blood 103:465\u201372","journal-title":"Blood"},{"key":"1102_CR30","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1073\/pnas.89.8.3325","volume":"89","author":"Marchalonis","year":"1992","unstructured":"Marchalonis JJ, Kaymaz H, Dedeoglu F, Schlutter SF, Yocum DE, Edmundson AB (1992) Human autoantibodies reactive with synthetic autoantigens from T-cell receptor \u03b2 chain. Proc Natl Acad Sci USA 89:3325\u20133329","journal-title":"Proc Natl Acad Sci USA"},{"key":"1102_CR31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/clin.1997.4329","volume":"83","author":"Modiano","year":"1997","unstructured":"Modiano JF,Amran D, Lack G, Bradley K, Ball C, Domenico J, Gelfand EW (1997) Posttranscriptional regulation of T-cell IL-2 production by human pooled immunoglobulin. Clin Immunol Immunopathol 83:77\u201385","journal-title":"Clin Immunol Immunopathol"},{"key":"1102_CR32","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1365-3083.1998.00386.x","volume":"48","author":"Mollnes","year":"1998","unstructured":"Mollnes TE, Hogasen K, De Carolis C, Vaquero E, Nielsen EW, Fontana L, Perricone R (1998) High-dose intravenous immunoglobulin treatment activates complement in vivo. Scand J Immunol 48:312\u2013317","journal-title":"Scand J Immunol"},{"key":"1102_CR33","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/(SICI)1521-4141(199806)28:06<1823::AID-IMMU1823>3.0.CO;2-F","volume":"28","author":"Pashov","year":"1998","unstructured":"Pashov A, Dubey C, Kaveri SV, Lectard B, Huang Y, Kazatchkine MD, Bellon B (1998) Normal immunoglobulin G protects against experimental allergic encephalomyelitis by inducing transferable T cell unresponsiveness to myelin basic protein. Eur J Immunol 28:1823\u20131831","journal-title":"Eur J Immunol"},{"key":"1102_CR34","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.4049\/jimmunol.161.7.3781","volume":"161","author":"Prasad","year":"1998","unstructured":"Prasad N, Papoff G, Zeuner A, Bonnin E, Kazatchkine MD, Ruberti G, Kaveri SV (1998) Therapeutic preparations of normal polyspecific immunoglobulin G (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway. J Immunol 161:3781\u20133790","journal-title":"J Immunol"},{"key":"1102_CR35","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/eji.1830250521","volume":"25","author":"Ruiz de Souza","year":"1995","unstructured":"Ruiz de Souza V, Carreno MP, Kaveri SV, Ledur A, Sadeghi H, Cavaillon JM, Kazatchkine MD, Haeffner-Cavaillon N (1995) Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin). Eur J Immunol 25:1267\u20131273","journal-title":"Eur J Immunol"},{"key":"1102_CR36","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","volume":"291","author":"Samuelsson","year":"2001","unstructured":"Samuelsson A, Towers T, Ravetch J (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291:484\u2013486","journal-title":"Science"},{"key":"1102_CR37","first-page":"2838","volume":"25","author":"Saoudi","year":"1993","unstructured":"Saoudi A, Hurez V, De KY, Kuhn J, Kaveri SV, Kazatchkine MD, Druet P, Bellon B (1993) Prevention of experimental autoimmune uveoretinitis by infusions of human therapeutic intravenous immunoglobulins in rats. Transplant Proc 25:2838\u20132839","journal-title":"Transplant Proc"},{"key":"1102_CR38","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2567.2002.01545.x","volume":"107","author":"Sewell","year":"2002","unstructured":"Sewell WA, Jolles S (2002) Immunomodulatory action of intravenous immunoglobulin. Immunology 107:387\u2013393","journal-title":"Immunology"},{"key":"1102_CR39","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1212\/WNL.52.9.1833","volume":"52","author":"Sharief","year":"1999","unstructured":"Sharief M, Ingram D, Swash M, Thompson E (1999) I. v. immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barr\u00e9 syndrome. Neurology 52:1833\u20131838","journal-title":"Neurology"},{"key":"1102_CR40","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1006\/bbrc.1999.1592","volume":"264","author":"Sooryanarayana","year":"1999","unstructured":"Sooryanarayana V, Prasad N, Bonnin E, Pashov A, Ben-Jilani K, Ameisen JC, Kazatchkine MD, Kaveri SV (1999) Phosphorylation of Bcl-2 and mitochondrial changes are associated with apoptosis of lymphoblastoid cells induced by normal immunoglobulin. Biochem Biophys Res Comm 264:896\u2013901","journal-title":"Biochem Biophys Res Comm"},{"key":"1102_CR41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-510X(02)00343-X","volume":"206","author":"Sorensen","year":"2003","unstructured":"Sorensen PS (2003) The role of intravenous immunoglobulin in the treatment of multiple sclerosis. J Neurol Sci 206:123\u2013130","journal-title":"J Neurol Sci"},{"key":"1102_CR42","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.50.5.1273","volume":"50","author":"Sorensen","year":"1998","unstructured":"Sorensen PS, Wanscher B, Jensen CV, Schreiber K, Blinkenberg M, Ravnborg M, Kirsmeier H, Larsen VA, Lee ML (1998) Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis. Neurology 50:1273\u20131281","journal-title":"Neurology"},{"key":"1102_CR43","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1182\/blood.V91.6.2054","volume":"91","author":"Svenson","year":"1998","unstructured":"Svenson M, Hansen MB, Ross C, Diamant M, Rieneck K, Nielsen H, Bendtzen K (1998) Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in Human IgG preparations. Blood 91:2054\u20132061","journal-title":"Blood"},{"key":"1102_CR44","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/brain\/awf193","volume":"125","author":"Van den Berg-Vos","year":"2002","unstructured":"Van den Berg-Vos RM, Franssen H, Wokke JH, Van den Berg LH (2002) Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. Brain 125:1875\u20131886","journal-title":"Brain"},{"key":"1102_CR45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/jnnp.57.Suppl.65","volume":"57","author":"van Engelen","year":"1994","unstructured":"van Engelen BG, Miller DJ, Pavelko KD, Hommes OR, Rodriguez M (1994) Promotion of remyelination by polyclonal immunoglobulin in Theiler\u2019s virus-induced demyelination and in multiple sclerosis. J Neurol Neurosurg Psychiatry 57(Suppl):65\u201368","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1102_CR46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00920789","volume":"12","author":"Van Schaik","year":"1992","unstructured":"Van Schaik IN, Lundkvist I, Vermeulen M, Brand A (1992) Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro. J Clin Immunol 12:325\u2013334","journal-title":"J Clin Immunol"},{"key":"1102_CR47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2249.1993.tb03407.x","volume":"92","author":"Vassilev","year":"1993","unstructured":"Vassilev T, Gelin C, Kaveri SV, Zilber MT, Boumsell L, Kazatchkine MD (1993) Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg). Clin Exp Immunol 92:369\u2013372","journal-title":"Clin Exp Immunol"},{"key":"1102_CR48","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1182\/blood.V93.11.3624","volume":"93","author":"Vassilev","year":"1999","unstructured":"Vassilev T, Kazatchkine MD, Duong Van Huyen JP, Mekrache M, Bonnin E, Korinth D, Baruch D, Mani JC, Lecroubier C, Schriever F, Kaveri SV (1999) Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (Intravenous Immunoglobulin, IVIg). Blood 93:3624\u20133631","journal-title":"Blood"},{"key":"1102_CR49","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","volume":"282","author":"Viard","year":"1998","unstructured":"Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282:490\u2013493","journal-title":"Science"},{"key":"1102_CR50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1027326731945","volume":"17","author":"Vuist","year":"1997","unstructured":"Vuist W, Van Schaik I, Van Lint M, Brand A (1997) The growth arresting effect of human immunoglobulin for intravenous use is mediated by antibodies recognizing membrane glycolipids. J Clin Immunol 17:301\u2013310","journal-title":"J Clin Immunol"},{"key":"1102_CR51","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.97.12.6820","volume":"97","author":"Warrington","year":"2000","unstructured":"Warrington AE, Asakura K, Bieber A, Ciric B, Van Keulen V, Kaveri SV, Kyle RA, Pease LR, Rodriguez M (2000) Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci (USA) 97:6820\u20136825","journal-title":"Proc Natl Acad Sci"},{"key":"1102_CR52","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199901213400311","volume":"340","author":"Yu","year":"1999","unstructured":"Yu Z, Lennon V (1999) Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med 340:227\u2013228","journal-title":"N Engl J Med"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-005-1102-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-005-1102-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-005-1102-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T11:42:06Z","timestamp":1683114126000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-005-1102-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":52,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["1102"],"URL":"https:\/\/doi.org\/10.1007\/s00415-005-1102-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}